| AAVS1 |
|
adeno-associated virus integration site 1
|
|
|
0.595 |
0.731 |
| AMD1P2 |
|
adenosylmethionine decarboxylase 1 pseudogene 2
|
|
|
0.608 |
0.538 |
| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| IDDM7 |
|
insulin dependent diabetes mellitus 7
|
|
|
0.861 |
0.192 |
| IDDM8 |
|
insulin dependent diabetes mellitus 8
|
|
|
0.821 |
0.192 |
| IDDM13 |
|
insulin dependent diabetes mellitus 13
|
|
|
0.890 |
0.192 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| RMRP |
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
|
0.519 |
0.731 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TRG |
|
T cell receptor gamma locus
|
|
|
0.631 |
0.538 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
| IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
| TRAJ60 |
|
T cell receptor alpha joining 60 (pseudogene)
|
|
|
0.751 |
0.346 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| SNHG32 |
|
small nucleolar RNA host gene 32
|
|
2.4E-02 |
0.805 |
0.308 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |